Cited by 427Endoplasmic Reticulum Stress and DiseaseGut microbiota and healthPer- and polyfluoroalkyl substances research

The DOI matches its Crossref record; 86 of the 88 references it cites were found in a registry or an index.

Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction

Open access

Chen, Sifan, Henderson, Ayana, Petriello, Michael C., Romano, Kymberleigh A., Gearing, Mary, Miao, Ji, Schell, Mareike, Sandoval-Espinola, Walter J., Tao, Jiahui, Sha, Bingdong, Graham, Mark, Crooke, Rosanne, Kleinridders, Andre, Balskus, Emily P., Rey, Federico E., Morris, Andrew J., Biddinger, Sudha B.·2019·Cell Metabolism

DOI 10.1016/j.cmet.2019.08.021

Open this paper in CoChat — free account Open PDF

Abstract

The gut-microbe-derived metabolite trimethylamine N-oxide (TMAO) is increased by insulin resistance and associated with several sequelae of metabolic syndrome in humans, including cardiovascular, renal, and neurodegenerative disease. The mechanism by which TMAO promotes disease is unclear. We now reveal the endoplasmic reticulum stress kinase PERK (EIF2AK3) as a receptor for TMAO: TMAO binds to PERK at physiologically relevant concentrations; selectively activates the PERK branch of the unfolded protein response; and induces the transcription factor FoxO1, a key driver of metabolic disease, in a PERK-dependent manner. Furthermore, interventions to reduce TMAO, either by manipulation of the gut microbiota or by inhibition of the TMAO synthesizing enzyme, flavin-containing monooxygenase 3, can reduce PERK activation and FoxO1 levels in the liver. Taken together, these data suggest TMAO and PERK may be central to the pathogenesis of the metabolic syndrome.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2019.08.021

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R. C., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,344
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,400
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
Kaser, A., Lee, A., Franke, A., Glickman, J. N., Zeißig, S., Tilg, H., Nieuwenhuis, E. E. S., Higgins, D. E., Schreiber, S., Glimcher, L. H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.021 · Cited by 1,465
FOXO transcription factors at the interface between longevity and tumor suppression
Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,340

Flagged first, then by citations

Show all 88 references

2 of the 88 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 424

Trimethylamine-N-oxide and cerebral stroke risk: A review
Dolkar, P., Deyang, T., Anand, N., Rathipriya, A. G., Hediyal, T. A., Vichitra, C., Krishnamoorthy, N. K., Gorantla, V. R., Bishir, M., Rashan, L. J., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106423 · Cited by 46
Healthy dietary patterns to reduce obesity-related metabolic disease: polyphenol-microbiome interactions unifying health effects across geography
Diotallevi, C., Fava, F., Gobbetti, M., & Tuohy, K. M. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000697 · Cited by 39
New insight into gut microbiota and their metabolites in ischemic stroke: A promising therapeutic target
Zhang, S., Jin, M., Ren, J., Sun, X., Zhang, Z., Luo, Y., & Sun, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114559 · Cited by 40
Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model
Lanz, M., Janeiro, M. H., Milagro, F. I., Puerta, E., Ludwig, I. A., Pineda‐Lucena, A., Ramírez, M. J., & Solas, M. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111668 · Cited by 40
Transplantation of fecal microbiota from APP/PS1 mice and Alzheimer’s disease patients enhanced endoplasmic reticulum stress in the cerebral cortex of wild-type mice
Wang, F., Gu, Y., Xu, C., Du, K., Zhao, C., Zhao, Y., & Liu, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858130 · Cited by 39
TMAO and diabetes: from the gut feeling to the heart of the problem
Jaworska, K., Kuś, M., & Ufnal, M. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00377-8 · Cited by 43
Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease
Zhao, Y., & Wang, Z. (2020) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2020.01.01 · Cited by 42
Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine
Shi, C., Pei, M., Wang, Y., Chen, Q., Cao, P., Zhang, L., Guo, J., Deng, W., Wang, L., Li, X., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.060 · Cited by 39
The Role of Microbiota-Derived Metabolites in Colorectal Cancer
Duizer, C., & de Zoete, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098024 · Cited by 38
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Li, M., Wang, H., Zhang, X., Cai, J., & Li, H. (2023) · Physiology · doi:10.1152/physiol.00013.2023 · Cited by 41
Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
Zhu, M., Dagah, O. M. A., Silaa, B. B., & Lu, J. (2023) · Antioxidants · doi:10.3390/antiox12091680 · Cited by 40
Association of trimethylamine N -Oxide with cardiovascular and all-cause mortality in hemodialysis patients
Zhang, P., Zou, J., Chen, J., Tan, X. Y., Xiang, F., Shen, B., Hu, J.-C., Wang, J., Wang, Y., Yu, J., et al. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1822868 · Cited by 37
Diet‐Induced High Serum Levels of Trimethylamine‐N‐oxide Enhance the Cellular Inflammatory Response without Exacerbating Acute Intracerebral Hemorrhage Injury in Mice
Li, C., Zhu, L., Dai, Y., Zhang, Z., Huang, L., Wang, T. J., Fu, P., Li, Y., Wang, J., & Jiang, C. Q. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1599747 · Cited by 37
Endoplasmic reticulum stress: a novel targeted approach to repair bone defects by regulating osteogenesis and angiogenesis
Wu, T., Jiang, Y., Shi, W., Wang, Y., & Li, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04328-8 · Cited by 37
Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension
Wang, Z., Shao, Y., Wu, F., Luo, D., He, G., Liang, J., Quan, X., Chen, X., Xia, W., Chen, Y., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127824 · Cited by 37
The gut microbiota in thrombosis
Khuu, M. P., Paeslack, N., Dremova, O., Benakis, C., Kiouptsi, K., & Reinhardt, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01070-6 · Cited by 36
Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives
Lu, Y., Yuan, H., Liang, S., Li, D., Jiang, P., Wang, X., Zhang, K., & Liu, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603658 · Cited by 41
Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
Cheng, W., Li, S., Lee, T.-I., Lee, T., Chung, C., Kao, Y., & Chen, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9070728 · Cited by 41
Gut microbiota mediated the toxicity of high concentration of dietary nitrite in C57BL/6 mice
Xu, J., Wang, M., Liu, Q., Lin, X., Pu, K., & He, Z. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113224 · Cited by 35
BCAA dysmetabolism in the host and gut microbiome, a key player in the development of obesity and T2DM
Li, N., Cen, Z., Zhao, Z., Li, Z., & Chen, S. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100078 · Cited by 38
Self-citation
Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways
Zhong, X., Zhang, F., Yin, X., Cao, H., Wang, X., Liu, D., Chen, J., & Chen, X. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2104.04016 · Cited by 35
Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
Kim, S.-J., Bale, S., Verma, P., Wan, Q., Ma, F., Gudjonsson, J. E., Hazen, S. L., Harms, P. W., Tsou, P., Khanna, D., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104669 · Cited by 36
Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites
Chakraborty, S., Lulla, A., Cheng, X., Yeo, J., Mandal, J., Yang, T., Mei, X., Saha, P., Golonka, R. M., Yeoh, B. S., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003423 · Cited by 34
Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target
Turpin, T., Thouvenot, K., & Gonthier, M. (2023) · Biomolecules · doi:10.3390/biom13121692 · Cited by 35
Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers – Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer
Saaoud, F., Lu, Y., Xu, K., Shao, Y., Praticò, D., Vázquez-Padrón, R. I., Wang, H., & Yang, X. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108604 · Cited by 33
Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases
Chen, N., Chan, C. K., Khan, F. U., Makhijani, P., Valentino, T. R., Winer, S., Luk, C. T., & Winer, D. A. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103036 · Cited by 37
How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?
Gerdes, V. E. A., Gueimonde, M., Pajunen, L., Nieuwdorp, M., & Laitinen, K. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.028 · Cited by 34
Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signaling
Liu, X., Shao, Y., Tu, J., Sun, J., Li, L., Tao, J., Chen, J., & Chen, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-5043 · Cited by 34
Self-citation
Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
Ben‐Azu, B., del Re, E. C., VanderZwaag, J., Carrier, M., Keshavan, M. S., Khakpour, M., & Tremblay, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1139357 · Cited by 32
The Influence of Polysaccharides on Lipid Metabolism: Insights from Gut Microbiota
Huang, Q., Zhang, Y., Chu, Q., & Song, H. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300522 · Cited by 33
Human Microbiome and Its Medical Applications
Zhang, Y., Zhou, L., Xia, J., Dong, C., & Luo, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.703585 · Cited by 32
Diet, Fecal Microbiome, and Trimethylamine N-Oxide in a Cohort of Metabolically Healthy United States Adults
James, K. L., Gertz, E., Cervantes, E., Bonnel, E. L., Stephensen, C. B., Kable, M. E., & Bennett, B. J. (2022) · Nutrients · doi:10.3390/nu14071376 · Cited by 30
Endoplasmic Reticulum Stress in Cancer
Zhou, R., Wang, W., Li, B., Zhu, L., Huang, J., & Li, X. (2025) · MedComm · doi:10.1002/mco2.70263 · Cited by 39
Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions
Krueger, E. S., Beales, J. L., Russon, K. B., Elison, W. S., Davis, J., Hansen, J. M., Neilson, A. P., Hansen, J. M., & Tessem, J. S. (2021) · Biomolecules · doi:10.3390/biom11121892 · Cited by 32
Connections between serum Trimethylamine N-Oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity
Mihuţa, M. S., Paul, C., Borlea, A., Roi, C. M., Pescari, D., Velea-Barta, O.-A., Mozos, I. M., & Stoian, D. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1253584 · Cited by 34
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance
Fu, B., Lou, Y., Wu, P., Lu, X., & Xu, C. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101017 · Cited by 31
Trimethylamine-N-oxide acutely increases cardiac muscle contractility
Oakley, C. I., Vallejo, J. A., Wang, D. D., Gray, M., Tiede-Lewis, L. M., Shawgo, T., Daon, E., Zorn, G. L., Stubbs, J. R., & Wacker, M. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00507.2019 · Cited by 30
Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa)
Barrea, L., Muscogiuri, G., Pugliese, G., de Alteriis, G., Maisto, M., Donnarumma, M., Tenore, G. C., Colao, A., Fabbrocini, G., & Savastano, S. (2021) · Nutrients · doi:10.3390/nu13061997 · Cited by 29
Short-chain fatty acid butyrate against TMAO activating endoplasmic-reticulum stress and PERK/IRE1-axis with reducing atrial arrhythmia
Cheng, T.-Y., Lee, T., Li, S., Lee, T.-I., Chen, Y., Kao, Y., Higa, S., Chen, P., & Chen, Y.-J. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.009 · Cited by 28
At the Intersection of Gut Microbiome and Stroke: A Systematic Review of the Literature
Sharma, V., Sharma, V., Shahjouei, S., Li, J., Chaudhary, D. P., Khan, A., Wolk, D. M., Zand, R., & Abedi, V. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.729399 · Cited by 30
Gut metabolite trimethylamine N-oxide induces aging-associated phenotype of midbrain organoids for the induced pluripotent stem cell-based modeling of late-onset disease
Lee, Y., Kang, J. S., Ham, O.-J., Son, M., & Lee, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.925227 · Cited by 27
The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host
Huang, J., & Mao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029033 · Cited by 27
Kinsenoside‐Loaded Microneedle Accelerates Diabetic Wound Healing by Reprogramming Macrophage Metabolism via Inhibiting IRE1α/XBP1 Signaling Axis
Lü, L., Liao, J., Xu, C., Xiong, Y., Zhou, J., Wang, G., Lin, Z., Zha, K., Lin, C., Zeng, R., et al. (2025) · Advanced Science · doi:10.1002/advs.202502293 · Cited by 26
Identification of choline-degrading bacteria from healthy human feces and used for screening of trimethylamine (TMA)-lyase inhibitors
Heng, X., Liu, W., & Chu, W. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104658 · Cited by 26
Exogenous microbiota-derived metabolite trimethylamine N-oxide treatment alters social behaviors: Involvement of hippocampal metabolic adaptation
Luo, Y., Zhao, P., Dou, M., Mao, J., Zhang, G., Su, Y., Wang, Q., Wang, Q., Wang, Y., Sun, R., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108563 · Cited by 26
Trimethylamine N-oxide—a marker for atherosclerotic vascular disease
Xie, G., An, Y., Lin, P., Wang, Y., & Guo, L. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2203085 · Cited by 27
The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies
Huang, R., Li, Y., & Lei, Y. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s339590 · Cited by 28
Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
He, Q., Dong, H., Guo, Y., Gong, M., Xia, Q., Lu, F., & Wang, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074348 · Cited by 27
Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease
Lei, Y., Xu, M., Huang, N., & Yuan, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1154888 · Cited by 26
Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention
Huang, Y., Wu, Y., Zhang, Y., Bai, H., Peng, R., Ruan, W., Zhang, Q., Cai, E., Ma, M., Zhao, Y., et al. (2024) · Nutrients · doi:10.3390/nu16111711 · Cited by 25
Trimethylamine N-oxide promotes PERK-mediated endothelial-mesenchymal transition and apoptosis thereby aggravates atherosclerosis
Wang, B., Jun, Q., Bingyang, L., Xi, Y., Jianqing, Z., & Jiangfang, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113209 · Cited by 24
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases
Zhang, Y., Wu, H., Jin, M., Feng, G., & Wang, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1572948 · Cited by 30
Trimethylamine- N -oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
Heinrich‐Sanchez, Y., & Vital, M. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2525403 · Cited by 27
Trimethylamine N-Oxide (TMAO) Inducing Endothelial Injury: UPLC-MS/MS-Based Quantification and the Activation of Cathepsin B-Mediated NLRP3 Inflammasome
Lei, D., Yu, W., Liu, Y. F., Jiang, Y., Li, X., Lv, J., & Li, Y. (2023) · Molecules · doi:10.3390/molecules28093817 · Cited by 24
Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
Li, Z., He, X., Fang, Q., & Yin, X. (2024) · Biomolecules · doi:10.3390/biom14111463 · Cited by 26
Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin
Huo, L., Li, H., Zhu, M., Liu, Y., Ren, L., Hu, J. H., & Wang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1257457 · Cited by 24
Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link
Saha, B., Banerjee, A., Pathak, R., Duttaroy, A. K., & Pathak, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118592 · Cited by 25
Role of gut microbe-derived metabolites in cardiometabolic diseases: Systems based approach
Cao, Y., Aquino-Martínez, R., Hutchison, E. R., Allayee, H., Lusis, A. J., & Rey, F. E. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101557 · Cited by 26
Self-citation
The microbial metabolite trimethylamine N-oxide and the kidney diseases
Su, J. Q., Wu, X., Wang, Q., Xie, B.-Y., Xiao, C.-Y., Su, H.-Y., Tang, J., & Yao, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1488264 · Cited by 28
Gut Microbiota‐Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers
Jin, J., Yang, X., Feng, R., Ye, M.-L., Xu, H., Wang, J., Hu, J., Zuo, H., Lu, J., Song, J., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501579rr · Cited by 24
Adipocyte FMO3-derived TMAO induces WAT dysfunction and metabolic disorders by promoting inflammasome activation in ageing
Ganapathy, T. P., Yuan, J.-T., Ho, M. Y.-M., Wu, K. K.-L., Hoque, M. M., Wang, B., Li, X., Wang, K., Wabitsch, M., Feng, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63905-1 · Cited by 22
Metabolic Interactions and Differences between Coronary Heart Disease and Diabetes Mellitus: A Pilot Study on Biomarker Determination and Pathogenesis
Liu, W., Guo, P., Dai, T., Shi, X., Shen, G., & Feng, J. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00879 · Cited by 22
Flavin-Containing Monooxygenase 3 (FMO3) Is Critical for Dioxin-Induced Reorganization of the Gut Microbiome and Host Insulin Sensitivity
Massey, W. J., Osborn, L. J., Banerjee, R., Horak, A. J., Fung, K. K., Orabi, D., Chan, E. R., Sangwan, N., Wang, Z., & Brown, J. M. (2022) · Metabolites · doi:10.3390/metabo12040364 · Cited by 21
Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
Kurilenko, N., Fatkhullina, A. R., Mazitova, A., & Koltsova, E. K. (2021) · Cells · doi:10.3390/cells10020348 · Cited by 22
Trimethylamine-N-oxide accelerates osteoporosis by PERK activation of ATF5 unfolding
Lin, Y.-H., Lian, W., Wu, R., Chen, Y., Wu, S.-L., Ko, J., Wang, S., Jahr, H., & Wang, F. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05501-y · Cited by 21
Neighborhood Environment Associates with Trimethylamine-N-Oxide (TMAO) as a Cardiovascular Risk Marker
Farmer, N. M., Gutierrez‐Huerta, C. A., Turner, B. S., Mitchell, V. M., Collins, B. S., Baumer, Y., Wallen, G. R., & Powell‐Wiley, T. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084296 · Cited by 21
Egg consumption improves vascular and gut microbiota function without increasing inflammatory, metabolic, and oxidative stress markers
Liu, X., Shao, Y., Sun, J., Tu, J., Wang, Z., Tao, J., & Chen, J. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2671 · Cited by 21
Self-citation
TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
Liu, X., Shao, Y., Tu, J., Sun, J., Dong, B., Wang, Z., Zhou, J., Chen, L., Tao, J., & Chen, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.804049 · Cited by 21
Self-citation
Bear bile powder ameliorates type 2 diabetes via modulation of metabolic profiles, gut microbiota, and metabolites
Chen, X.-L., Cai, K., Zhang, W., Su, S., Zhao, L.-H., Qiu, L., & Duan, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1090955 · Cited by 22
Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
Das, S., & Ramanathan, G. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121414 · Cited by 21
Identification of Polymethoxyflavones (PMFs) from Orange Peel and Their Inhibitory Effects on the Formation of Trimethylamine (TMA) and Trimethylamine-N-oxide (TMAO) Using cntA/B and cutC/D Enzymes and Molecular Docking
Lee, H., Liu, X., An, J., & Wang, Y. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c04462 · Cited by 21
Blueberry intervention mitigates detrimental microbial metabolite trimethylamine N‐oxide by modulating gut microbes
Babu, A. K. S., Petersen, C., Iglesias‐Carres, L., Paz, H. A., Wankhade, U. D., Neilson, A. P., & Babu, P. V. A. (2023) · BioFactors · doi:10.1002/biof.2014 · Cited by 21
The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies
Etlin, S. M., Rose, J. K., Bielski, L., Walter, C. E., Kleinman, A. S., & Mason, C. E. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00163-22 · Cited by 26
Mechanistic Links Between Gut Dysbiosis, Insulin Resistance, and Autism Spectrum Disorder
Guevara‐Ramírez, P., Tamayo‐Trujillo, R., Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Paz‐Cruz, E., & Zambrano, A. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136537 · Cited by 21
The emerging roles of PHOSPHO1 and its regulated phospholipid homeostasis in metabolic disorders
Liu, Y., Wu, Y., & Jiang, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.935195 · Cited by 20
Association between the Changes in Trimethylamine N-Oxide-Related Metabolites and Prognosis of Patients with Acute Myocardial Infarction: A Prospective Study
Li, N., Wang, Y., Zhou, J., Chen, R., Li, J., Zhao, X., Zhou, P., Liu, C., Chen, Y., Song, L., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110380 · Cited by 21
Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review
Das, S., Rajeswari, V. D., Venkatraman, G., Elumalai, R., Sivaraman, D., & Ramanathan, G. (2023) · Translational research · doi:10.1016/j.trsl.2023.11.002 · Cited by 22
The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease
Pan, S., Zhao, D., Duan, S., & Chen, X. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03500-9 · Cited by 22
The Role of Gut Microbiota in Host Lipid Metabolism: An Eye on Causation and Connection
Wang, K., Liang, X., Pang, Y., & Jiang, C. (2019) · Small Methods · doi:10.1002/smtd.201900604 · Cited by 19
Phenolipid JE improves metabolic profile and inhibits gluconeogenesis via modulating AKT-mediated insulin signaling in STZ-induced diabetic mice
Wang, G., Xu, J., Ma, H., Mu, Y., Xu, W., Yan, N., Liu, W., Zheng, D., Huang, X., & Li, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106569 · Cited by 19
Exploring the roles of intestinal flora in enhanced recovery after surgery
Liu, Z., Li, N., Dang, Q., Liu, L., Wang, L., Li, H., & Han, X. (2023) · iScience · doi:10.1016/j.isci.2023.105959 · Cited by 24
The role of small intestinal bacterial overgrowth in obesity and its related diseases
Yao, Q., Yu, Z., Meng, Q., Chen, J., Liu, Y., Song, W., Ren, X., Zhou, J., & Chen, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115546 · Cited by 19
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Zhou, Y., Lv, J., Jin, S., Fu, C., Liu, B., Shen, Y., Li, M., Zhang, Y., & Feng, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1526051 · Cited by 20
Gut microbiota–derived metabolite trimethylamine N-oxide alters the host epigenome through inhibition of S-adenosylhomocysteine hydrolase
Han, J. H., Rey, F. E., & Denu, J. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110521 · Cited by 21
Self-citation
Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control
Chilloux, J., Brial, F., Everard, A., Smyth, D. R., Andrikopoulos, P., Zhang, L., Plovier, H., Myridakis, A., Hoyles, L., Moreno‐Navarrete, J. M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01413-8 · Cited by 24
Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease.
Wu, R., Ruan, X., Ruan, D., Zhang, J., Wang, H.-L., Zeng, Q.-Z., Lu, T., Gan, Y., Luo, J.-W., & Wu, J. (2021) · PubMed Central · Cited by 18
Microbiota‐related metabolites fueling the understanding of ischemic heart disease
Fan, Y., Ying, J., Ma, H., & Cui, H. (2023) · iMeta · doi:10.1002/imt2.94 · Cited by 18
Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
Malik, A., Bagchi, A. K., Jassal, D. S., & Singal, P. K. (2022) · Biomedicines · doi:10.3390/biomedicines10040890 · Cited by 22
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
Gut microbiota-generated metabolites: missing puzzles to hosts’ health, diseases, and aging
Zhang, Y., Wei, S., Zhang, H., Jo, Y., Kang, J., Ha, K., Joo, J., Lee, H. J., & Ryu, D. (2024) · BMB Reports · doi:10.5483/bmbrep.2024-0022 · Cited by 18
Effect of three oral pathogens on the TMA-TMAO metabolic pathway
Wang, X., Chen, L., Teng, Y., Xie, W., Huang, L., Wu, J., Wang, H., & Xie, S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1413787 · Cited by 18
Targeting the Gut-Kidney Axis in Diarrhea with Kidney-Yang Deficiency Syndrome: The Role of Sishen Pills in Regulating TMAO-Mediated Inflammatory Response
Xie, S., Fang, L., Deng, N., Shen, J., Tan, Z., & Peng, X. (2024) · Medical Science Monitor · doi:10.12659/msm.944185 · Cited by 17
Microbiome and Cardiovascular Disease
Herrema, H., Nieuwdorp, M., & Groen, A. K. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_356 · Cited by 17
The coupling of translational control and stress responses
Houston, R., Sekine, S., & Sekine, Y. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa061 · Cited by 17
Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies
Zhu, B., Ren, H., Xie, F., An, Y., Wang, Y., & Tan, Y. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220919085019 · Cited by 18
Dietary supplementation of l -carnitine ameliorates metabolic syndrome independent of trimethylamine N -oxide produced by gut microbes in high-fat diet-induced obese mice
Gao, X., Sun, C., Zhang, Y., Hu, S., & Li, D. (2022) · Food & Function · doi:10.1039/d2fo02570a · Cited by 17
Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons
Liu, J., Ge, P., Luo, Y., Sun, Z., Luo, X., Li, H., Pei, B., Xun, L., Zhang, X., Jiang, Y., et al. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s512207 · Cited by 20
The modulation effects of plant‐derived bioactive ingredients on chronic kidney disease: Focus on the gut–kidney axis
Jian, S., Yang, K., Zhang, L., Zhang, L., Xin, Z., Wen, C., He, S., Deng, J., & Deng, B. (2023) · Food Frontiers · doi:10.1002/fft2.209 · Cited by 16
Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
Berezin, A. A., Obradovic, Z., Berezina, T. A., Boxhammer, E., Lichtenauer, M., & Berezin, A. Е. (2023) · Antioxidants · doi:10.3390/antiox12020516 · Cited by 17
Ethanol‐Induced Hepatic Ferroptosis Is Mediated by PERK‐Dependent MAMs Formation: Preventive Role of Quercetin
Lin, H., Guo, X., Liu, J., Tang, Y., Chen, L., Chen, H., Zhao, Y., Wang, L., Li, H., Yu, J., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300343 · Cited by 16

Authors: Chen, S., Henderson, A., Petriello, M. C., Romano, K. A., Gearing, M., Miao, J., Schell, M., Sandoval-Espinola, W. J., Tao, J., Sha, B., Graham, M., Crooke, R., Kleinridders, A., Balskus, E. P., Rey, F. E., Morris, A. J., & Biddinger, S. B.
Affiliations: Boston Children's Hospital (US)
University of Kentucky (US)
University of Wisconsin–Madison (US)
German Center for Diabetes Research (DE)
University of Alabama at Birmingham (US)
Ionis Pharmaceuticals (United States) (US)
Harvard University (US)
Corresponding author: Biddinger, Sudha B.
ORCID: Chen, Sifan
Henderson, Ayana
Petriello, Michael C.
Miao, Ji
Schell, Mareike
Tao, Jiahui
Sha, Bingdong
Balskus, Emily P.
Rey, Federico E.
Morris, Andrew J.
Biddinger, Sudha B.
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2019-12
Volume: 30
Issue: 6
Pages: 1141-1151.e5
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2019.08.021
OpenAlex: W2973552995
Cited by: 427
References: 88
Citations by year: 2026: 60 · 2025: 84 · 2024: 63 · 2023: 69 · 2022: 60 · 2021: 50 · 2020: 36 · 2019: 2
FWCI: 19.49
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
Bundesministerium für Bildung und Forschung
American Heart Association (R01HL109650)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
Keywords: trimethylamine N-oxide, PERK, unfolded protein response, endoplasmic reticulum stress, FOXO1, gut microbiota, FMO3, metabolic syndrome, insulin resistance, liver
MeSH terms: Gastrointestinal Microbiome, Animals, Humans, Indoles, Insulin Resistance, Methylamines, Mice, Inbred C57BL, Mice, Obese, Oxygenases, Mice, Knockout, eIF-2 Kinase, Metabolic Syndrome, Mice, Hep G2 Cells, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks